Clinically, NEDD4 is higher expressed in IGF1-high GC tissues compared with IGF1-low GC tissues and normal tissues, and the co-high expression of NEDD4 and IGF1 predicts a worse prognosis of patients with GC. Here, NEDD4 is linked to gastric cancer.